Edward D. Esplin, Clinical Geneticist at Invitae, shared a recent article on LinkedIn:
“Universal Germline Genetic Testing Standard of Care for Patients with Prostate Cancer: The Time Is Now.
We recommend that all patients with prostate cancer should be offered comprehensive germline genetic testing”
Authors: Neal Shore, Sarah M. Nielsen, Edward D. Esplin, Emmanuel S. Antonarakis, Pedro C. Barata, Tomasz M. Beer, Himisha Beltran, Alan Bryce, Michael S. Cookson, E. David Crawford, Tanya B. Dorff, Daniel J. George, Elisabeth I. Heath, Brian T. Helfand, Maha Hussain, Rana R. Mckay, Alicia K. Morgans, Michael J. Morris, Channing J. Paller, Ashley E. Ross, Oliver Sartor, John Shen, Paul Sieber, Matthew R. Smith, David R. Wise and Andrew J. Armstrong
Correlation with PROCLAIM trial:
More posts featuring Edward D. Esplin.